Product Overview of Paige.AI
Paige.AI is a cutting-edge platform that leverages advanced artificial intelligence (AI) to transform the field of pathology and oncology, particularly in the diagnosis and treatment of cancer.
What Paige.AI Does
Paige.AI is designed to support pathologists, oncologists, and multidisciplinary clinical teams by providing AI-driven tools for managing, analyzing, and diagnosing cancer cases. The platform integrates state-of-the-art computational pathology with large vision models (LVMs) and large language models (LLMs) to enhance diagnostic accuracy, efficiency, and collaboration.
Key Features and Functionality
AI-Driven Diagnostic Tools
- Paige.AI offers a suite of AI applications tailored for specific types of cancer, including the Paige Prostate Suite, Paige Breast Suite, and Paige Colon Suite. These applications aid in the detection and diagnosis of cancer on H&E-stained whole-slide images, leveraging robust machine learning models validated against extensive datasets.
Paige Alba™
- Paige Alba is a groundbreaking multimodal co-pilot that combines patient data from various sources such as electronic health records (EHRs), laboratory information systems (LIS), and imaging management systems (IMS) into a single, cohesive view. It provides real-time AI-driven patient insights, enhances decision-making by analyzing clinical, pathological, and biomarker data, and automates report generation using voice commands.
FullFocus® Viewer
- The platform includes the FDA-cleared and CE-marked FullFocus® viewer, a browser-based tool for primary diagnosis. This viewer offers advanced digital measurement, annotation, and collaboration tools, ensuring high-quality diagnostic capabilities.
Data Aggregation and Integration
- Paige.AI seamlessly integrates with major scanners and LIS vendors, supports DICOM files, and offers viewing capabilities for H&E and IHC-stained slides. It also provides APIs and a software development kit (SDK) for extending the platform’s functionality and integrating third-party AI applications.
Security and Compliance
- The platform ensures secure cloud-based storage and is ISO 27001:2013 certified, ensuring the protection of sensitive patient data.
Enhanced Collaboration and Efficiency
- Paige.AI facilitates collaboration among healthcare professionals by providing a comprehensive and interactive experience. It reduces administrative tasks, allowing pathologists to focus on core responsibilities, and enhances diagnostic accuracy through AI-driven image analysis.
Biomarker Discovery and Treatment Response
- The platform includes AI applications such as Paige OmniScreen™, which detects phenotypic changes associated with genetic alterations in cancer. These tools help in identifying key mutations and pathways critical to cancer progression, enabling more personalized treatment plans.
In summary, Paige.AI is a comprehensive and innovative solution that leverages AI to revolutionize pathology workflows, enhance diagnostic precision, and support personalized medicine in cancer care. Its robust features and functionalities make it a leading tool in the field of computational pathology.